Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Chris Lavictoire Mahai

Director at abrdn Healthcare Investors (HQH); Director at abrdn Life Sciences Investors (HQL); Director at abrdn Healthcare Opportunities Fund (THQ); Director at abrdn World Healthcare Fund (THW)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys−$3K
Total bought / sold$42K / $0

Reported trades

Filed Stock Type Shares Price Value Since
Jul 20SEC HQHabrdn Healthcare Investors Buy 501new position $20.96 $11K -4.9%
Jul 20SEC THWabrdn World Healthcare Fund Buy 796new position $13.20 $11K -7.0%
Jul 20SEC THQabrdn Healthcare Opportunities Fund Buy 568new position $18.49 $11K -3.4%
Jul 20SEC HQLabrdn Life Sciences Investors Buy 527new position $19.92 $10K -8.9%
  • Buy

    Director Chris Lavictoire Mahai bought $11K of HQH at $20.96 — first open-market purchase in our records; opens a new position.

  • Buy

    Director Chris Lavictoire Mahai bought $11K of THW at $13.20 — first open-market purchase in our records; opens a new position.

  • Buy

    Director Chris Lavictoire Mahai bought $11K of THQ at $18.49 — first open-market purchase in our records; opens a new position.

  • Buy

    Director Chris Lavictoire Mahai bought $10K of HQL at $19.92 — first open-market purchase in our records; opens a new position.